Drug: ETOPOSIDE. Injury: Disease progression Quarter: 2016Q3
Total Records: 51 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125425321 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125425341 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125425351 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125425461 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125425471 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | JP | |
| 125426411 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125426421 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125426441 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125524831 | ETOPOSIDE. | Disease progression | PFIZER | 9.00 YR | F | 0 | 20160713 | US |
| 126067943 | ETOPOSIDE. | Disease progression | TEVA | 24.00 YR | M | 0 | 20160817 | IT |
| 126292581 | ETOPOSIDE. | Disease progression | RANBAXY | 52.00 YR | M | 0 | 20160808 | CA |
| 126296132 | ETOPOSIDE. | Disease progression | TEVA | 0.00 | F | 0 | 20160825 | GB |
| 126406134 | ETOPOSIDE. | Disease progression | PFIZER | 0.00 | F | 0 | 20160902 | GB |
| 126438742 | ETOPOSIDE. | Disease progression | CONCORDIA | 0.00 | F | 0 | 20160822 | GB |
| 126487362 | ETOPOSIDE. | Disease progression | JANSSEN | 0.00 | F | 0 | 20160816 | GB |
| 126516702 | ETOPOSIDE. | Disease progression | PFIZER | 0.00 | F | 0 | 20160829 | GB |
| 126532702 | ETOPOSIDE. | Disease progression | BAUSCH AND LOMB | 0.00 | F | 0 | 20160816 | GB |
| 126628233 | ETOPOSIDE. | Disease progression | PFIZER | 62.00 YR | F | 0 | 20160901 | GB |
| 126672261 | ETOPOSIDE. | Disease progression | CIPLA | 0.00 | 0 | 20160819 | US | |
| 126754753 | ETOPOSIDE. | Disease progression | ACCORD | 0.00 | F | 0 | 20160906 | GB |
Total Records: 51 Number of Pages: 3